data_1k3k_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1k3k _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.486 1.352 0 CA-C-O 120.794 0.331 . . . . 6.0499999999999998 111.214 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -163.87 32.73 0.08 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.191 -0.459 . . . . 2.6299999999999999 110.868 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -56.18 90.91 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.188 -0.46 . . . . 2.8399999999999999 110.952 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -105.75 36.89 2.39 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.18 -0.464 . . . . 3.6099999999999999 110.742 179.854 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 12.7 t 52.35 25.91 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.056 -0.52 . . . . 3.1499999999999999 111.44 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 10.1 tp -178.75 56.67 0.09 OUTLIER Pre-proline 0 C--N 1.331 -0.213 0 CA-C-O 120.96 0.41 . . . . 2.8100000000000001 110.779 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -65.65 -29.42 51.79 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.718 2.278 . . . . 1.3300000000000001 112.298 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -159.23 163.73 33.52 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.812 -0.708 . . . . 0.72999999999999998 112.351 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.411 ' HB3' ' CZ ' ' A' ' 128' ' ' PHE . 4.5 mm-40 -79.86 -57.32 3.71 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.871 0.367 . . . . 1.3200000000000001 110.882 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 33.3 m -78.5 -34.92 18.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.104 -0.498 . . . . 1.1000000000000001 111.607 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 9.1 tt -51.77 -28.41 15.26 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.272 -0.422 . . . . 2.04 111.237 -179.627 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -67.93 -41.43 82.59 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.362 -0.381 . . . . 1.0600000000000001 111.509 -179.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.405 ' O ' ' CD2' ' A' ' 17' ' ' PHE . 21.8 pt -80.05 -37.61 17.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.501 -0.318 . . . . 1.0900000000000001 111.844 -179.445 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -60.49 -37.03 79.76 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.836 0.351 . . . . 1.78 111.052 -179.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -81.55 -52.05 4.34 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.683 -0.77 . . . . 0.47999999999999998 112.733 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 3.2 mt -59.36 -19.98 17.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 N-CA-C 112.045 0.387 . . . . 1.1799999999999999 112.045 -179.577 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.405 ' CD2' ' O ' ' A' ' 13' ' ' ILE . 8.1 m-85 -91.52 -57.41 2.77 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 112.382 0.512 . . . . 2.1600000000000001 112.382 -179.185 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 16.1 mmt -84.46 -24.59 29.43 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.148 0.425 . . . . 1.1299999999999999 112.148 -178.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -97.13 -51.08 4.34 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.077 0.399 . . . . 1.0600000000000001 112.077 -179.355 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 4.2 t -86.31 -26.01 25.14 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 111.769 0.285 . . . . 1.97 111.769 -179.216 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -48.14 -28.9 6.33 Favored Glycine 0 C--N 1.33 0.212 0 C-N-CA 120.585 -0.817 . . . . 0.51000000000000001 112.69 -179.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -73.98 -34.71 64.32 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.845 0.355 . . . . 1.55 110.868 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 2.0 t30 -147.11 105.98 3.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.228 -0.442 . . . . 2.5899999999999999 110.881 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 12.3 mt-10 -96.4 104.38 17.4 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.226 -0.443 . . . . 2.1400000000000001 110.96 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -67.01 129.4 20.6 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.211 1.94 . . . . 2.02 112.283 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 59.3 mt-10 -108.58 34.49 3.63 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.19 -0.459 . . . . 2.9399999999999999 110.98 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.419 ' CD1' ' N ' ' A' ' 28' ' ' LEU . 41.8 p90 -117.31 -42.97 2.86 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.185 -0.461 . . . . 3.8300000000000001 110.873 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.419 ' N ' ' CD1' ' A' ' 27' ' ' TYR . 12.4 tp -144.0 136.76 27.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.147 -0.478 . . . . 2.9700000000000002 110.799 179.827 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -127.59 87.04 2.56 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.21 -0.45 . . . . 2.0600000000000001 110.423 -179.896 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -67.1 -52.28 31.47 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.308 -0.405 . . . . 2.5499999999999998 111.612 -179.418 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_exo -59.45 -157.39 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.297 1.998 . . . . 0.83999999999999997 112.027 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 1.7 pp -44.63 138.99 3.09 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 116.289 -0.414 . . . . 1.1100000000000001 111.057 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 3.9 mp -49.33 -91.55 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.299 -0.41 . . . . 1.49 110.605 -179.719 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.479 ' N ' ' CD ' ' A' ' 35' ' ' PRO . 36.4 p -151.86 41.72 0.21 Allowed Pre-proline 0 CA--C 1.534 0.352 0 N-CA-C 112.396 0.517 . . . . 0.94999999999999996 112.396 179.217 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.479 ' CD ' ' N ' ' A' ' 34' ' ' SER . 54.2 Cg_endo -72.56 -51.22 0.2 Allowed 'Trans proline' 0 C--N 1.353 0.786 0 C-N-CA 121.786 1.657 . . . . 0.22 111.511 178.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 7.1 mm -81.11 -29.73 11.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.718 -0.673 . . . . 1.1599999999999999 110.903 179.541 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.91 -49.1 76.62 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.286 -0.415 . . . . 2.4399999999999999 110.543 179.844 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 81.2 mt -72.41 -44.52 62.35 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.147 -0.478 . . . . 1.53 110.517 179.642 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.438 ' CE2' ' CD2' ' A' ' 137' ' ' LEU . 2.7 m-85 -54.38 -52.32 62.02 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.121 -0.49 . . . . 2.1299999999999999 110.782 179.72 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 9.1 pt -68.04 -40.98 84.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.983 -0.553 . . . . 1.0600000000000001 111.31 -179.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.1 m -61.16 -38.69 87.34 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.247 -0.433 . . . . 1.0700000000000001 111.35 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -66.68 -53.04 30.03 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.722 -0.751 . . . . 0.25 112.777 -179.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -62.59 -52.36 63.7 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.795 0.331 . . . . 1.1899999999999999 111.003 -179.9 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -48.97 -28.05 3.59 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.205 -0.452 . . . . 1.5 111.284 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 7.3 ttt180 -67.32 -55.01 15.6 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.735 0.302 . . . . 3.8799999999999999 111.326 -179.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -82.03 -52.33 7.14 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.363 -0.381 . . . . 1.3500000000000001 111.44 -179.488 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.416 ' HB3' ' CE2' ' A' ' 51' ' ' PHE . 7.5 mmtt -55.52 -21.97 19.15 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.283 -0.417 . . . . 1.1899999999999999 111.878 -179.578 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 -45.57 -45.88 13.85 Favored 'General case' 0 N--CA 1.462 0.127 0 CA-C-O 120.778 0.323 . . . . 1.74 111.232 -179.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 87.5 p -54.78 -30.58 57.18 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.292 -0.413 . . . . 0.87 110.884 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.415 ' CD2' ' CD1' ' A' ' 51' ' ' PHE . 6.2 tt -81.82 -54.01 5.71 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.264 -0.425 . . . . 1.1899999999999999 111.085 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . 0.416 ' CE2' ' HB3' ' A' ' 47' ' ' LYS . 17.4 m-85 -59.33 -46.77 87.7 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.403 -0.362 . . . . 2.1899999999999999 111.059 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -50.87 -28.02 8.66 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.361 -0.381 . . . . 1.4399999999999999 111.329 -179.675 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -79.28 -35.78 40.81 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.826 0.346 . . . . 1.02 111.358 -179.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 58.2 ttp -84.1 -41.71 16.84 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.285 -0.416 . . . . 1.23 111.244 -179.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 6.9 mp -81.05 -59.05 2.8 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 112.384 0.512 . . . . 1.0900000000000001 112.384 -179.196 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -72.07 -44.62 63.0 Favored 'General case' 0 N--CA 1.463 0.22 0 N-CA-C 113.467 0.914 . . . . 0.93000000000000005 113.467 -177.804 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 23.9 t30 -92.1 28.91 1.74 Allowed 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.311 0.485 . . . . 1.6899999999999999 112.311 -178.652 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.4 ' CG2' ' N ' ' A' ' 59' ' ' ARG . 0.5 OUTLIER 167.71 150.65 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 120.815 0.341 . . . . 1.3200000000000001 110.983 179.694 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.4 ' N ' ' CG2' ' A' ' 58' ' ' VAL . 2.6 mpt_? -86.73 104.24 15.94 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.296 -0.411 . . . . 3.3100000000000001 110.45 179.787 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.431 ' CG ' ' CD1' ' A' ' 107' ' ' LEU . 2.8 p90 -46.68 121.32 3.45 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.243 -0.435 . . . . 1.74 111.181 -179.471 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.419 ' CD2' ' HA3' ' A' ' 65' ' ' GLY . 0.4 OUTLIER -70.48 65.65 0.3 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.875 -0.602 . . . . 1.05 111.637 -179.574 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 44.52 -166.77 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.008 -0.542 . . . . 1.5 111.655 179.265 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.428 ' HB ' ' CG ' ' A' ' 110' ' ' PHE . 5.8 t -76.24 -23.82 54.55 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.915 -0.584 . . . . 1.02 111.974 -179.699 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 6.9 t -50.03 -46.76 53.29 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.737 0.303 . . . . 1.24 111.313 -179.467 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.419 ' HA3' ' CD2' ' A' ' 61' ' ' HIS . . . -82.24 -47.05 6.27 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.634 -0.793 . . . . 0.25 113.143 -179.749 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 28.3 mm -62.95 -43.08 98.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 N-CA-C 111.894 0.331 . . . . 1.1299999999999999 111.894 -179.317 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -46.85 -58.08 4.27 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.87 0.367 . . . . 1.48 111.301 -179.709 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 39.9 tt0 -56.04 -31.3 63.02 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.322 -0.399 . . . . 1.6100000000000001 111.319 -179.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 16.9 tp -80.2 -61.04 2.1 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.347 -0.388 . . . . 1.8700000000000001 111.718 -179.528 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -80.68 -55.15 3.45 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.752 -0.737 . . . . 0.23999999999999999 113.338 -179.202 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.424 HD13 ' CZ ' ' A' ' 118' ' ' TYR . 0.2 OUTLIER -52.68 -25.24 10.36 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.771 0.32 . . . . 1.4099999999999999 111.016 -179.544 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -51.65 -25.54 7.32 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.701 -0.227 . . . . 1.26 111.198 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -49.77 -30.73 10.07 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.748 0.309 . . . . 1.0600000000000001 110.96 179.894 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -69.88 -52.05 28.0 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.271 -0.422 . . . . 1.95 110.957 -179.785 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 30.2 tt0 -53.92 -30.43 46.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.258 -0.428 . . . . 2.1699999999999999 110.97 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 6.6 p -94.27 -29.13 4.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.216 -0.447 . . . . 1.2 111.318 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 43.3 t -96.2 40.01 1.14 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.36 -0.382 . . . . 1.47 111.062 -179.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -65.41 -27.9 72.99 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.689 -0.767 . . . . 1.4299999999999999 112.354 179.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -176.38 88.21 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.86 0.362 . . . . 3.1000000000000001 110.837 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -122.05 -144.67 6.86 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.75 -0.738 . . . . 2.23 112.576 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 66.1 m-20 -128.29 98.13 4.98 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.819 0.342 . . . . 2.9500000000000002 110.998 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' MET . . . . . 0.404 ' HA ' ' CZ2' ' A' ' 127' ' ' TRP . 3.8 mtp 49.1 93.75 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.23 -0.441 . . . . 1.1200000000000001 110.97 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 7.6 m120 -123.01 49.62 1.63 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.205 -0.452 . . . . 1.95 110.916 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 8.4 m95 -49.64 -33.41 15.43 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.297 -0.411 . . . . 0.73999999999999999 110.791 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -56.12 -34.68 62.71 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.707 -0.758 . . . . 0.20000000000000001 112.313 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 8.3 mpt_? -64.41 -72.11 0.16 Allowed 'General case' 0 C--O 1.235 0.308 0 CA-C-O 121.011 0.434 . . . . 2.3700000000000001 110.647 179.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -50.68 -33.72 23.8 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.042 -0.527 . . . . 1.0 110.219 179.392 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 17.1 tp -66.79 -32.45 73.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.828 -0.624 . . . . 1.4099999999999999 110.432 179.364 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -57.47 -53.57 56.65 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.975 -0.557 . . . . 0.98999999999999999 111.023 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 4.8 tt -78.52 -29.22 14.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 C-N-CA 120.938 -0.305 . . . . 1.1299999999999999 111.152 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 19.3 mt -66.49 -65.16 0.71 Allowed 'General case' 0 C--O 1.233 0.23 0 CA-C-O 121.031 0.443 . . . . 1.8999999999999999 110.115 179.336 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 48.3 m -54.43 -41.46 69.4 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.033 -0.531 . . . . 1.03 109.963 179.136 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.428 ' CD1' HG11 ' A' ' 97' ' ' VAL . 8.7 t80 -51.02 -41.43 59.79 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 115.721 -0.672 . . . . 0.20999999999999999 109.946 179.207 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -59.79 -40.88 97.26 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.816 -0.707 . . . . 0.14999999999999999 112.146 179.516 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 1.3 t -66.27 -54.08 29.16 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.096 0.474 . . . . 0.87 110.713 179.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 23.6 t80 -57.92 -57.04 14.56 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.963 -0.562 . . . . 1.95 110.539 179.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.428 HG11 ' CD1' ' A' ' 93' ' ' PHE . 10.4 m -59.52 -35.18 57.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.891 -0.595 . . . . 1.04 110.899 179.84 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -50.07 -38.73 39.57 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.024 0.44 . . . . 1.0600000000000001 110.144 179.3 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -69.37 -39.46 78.05 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.813 -0.63 . . . . 2.1000000000000001 110.301 179.125 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -83.01 -2.0 54.12 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 116.006 -0.543 . . . . 1.5 112.039 179.859 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -88.23 -15.76 35.05 Favored 'General case' 0 N--CA 1.462 0.144 0 N-CA-C 112.013 0.375 . . . . 1.48 112.013 -179.544 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 4.0 t -51.45 -26.93 8.97 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.652 0.263 . . . . 1.3 110.766 -179.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -101.29 -29.64 11.95 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.483 -0.326 . . . . 1.9099999999999999 110.892 179.576 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -130.23 95.45 27.66 Favored Pre-proline 0 C--N 1.331 -0.21 0 CA-C-N 116.31 -0.405 . . . . 1.5600000000000001 110.855 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -71.49 -4.76 15.64 Favored 'Trans proline' 0 CA--C 1.532 0.381 0 C-N-CA 122.739 2.293 . . . . 1.0600000000000001 113.559 -179.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 62.0 m170 -49.65 -52.12 33.06 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.707 0.289 . . . . 2.1600000000000001 111.206 -179.501 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.446 ' O ' ' CD1' ' A' ' 110' ' ' PHE . 21.4 mt -73.04 -22.27 60.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.89 0.376 . . . . 1.1000000000000001 111.151 179.752 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 1.7 ttp180 -75.49 -20.84 58.51 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.679 0.276 . . . . 2.1400000000000001 111.096 179.594 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -73.48 -51.31 17.58 Favored 'General case' 0 C--O 1.234 0.248 0 N-CA-C 111.815 0.302 . . . . 1.0900000000000001 111.815 -179.548 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.446 ' CD1' ' O ' ' A' ' 107' ' ' LEU . 2.5 p90 -65.81 -41.9 91.31 Favored 'General case' 0 C--O 1.224 -0.286 0 C-N-CA 120.782 -0.367 . . . . 1.3100000000000001 110.472 -179.313 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.446 ' N ' ' CG ' ' A' ' 110' ' ' PHE . . . -45.73 -30.81 1.73 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.876 0.369 . . . . 1.03 111.419 -179.871 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 36.1 mt -81.06 -44.54 17.88 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.373 -0.376 . . . . 1.1899999999999999 111.262 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -89.43 2.54 54.34 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 113.207 0.818 . . . . 1.04 113.207 -179.093 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.408 HG13 ' N ' ' A' ' 115' ' ' LEU . 1.2 t -132.16 -51.14 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.138 0 N-CA-C 112.797 0.666 . . . . 1.05 112.797 -178.396 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.438 ' N ' ' HD2' ' A' ' 116' ' ' PRO . 0.3 OUTLIER -49.65 -56.56 16.1 Favored Pre-proline 0 C--N 1.328 -0.362 0 N-CA-C 111.969 0.359 . . . . 1.0800000000000001 111.969 -178.701 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.438 ' HD2' ' N ' ' A' ' 115' ' ' LEU . 30.3 Cg_endo -63.12 -51.18 2.96 Favored 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 122.019 1.813 . . . . 0.44 112.839 -179.584 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -57.02 -54.0 51.65 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.301 -0.409 . . . . 1.04 111.954 -179.366 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . 0.424 ' CZ ' HD13 ' A' ' 71' ' ' LEU . 9.0 m-85 -71.83 -26.03 62.21 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.409 -0.359 . . . . 2.0600000000000001 111.88 -179.21 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -56.53 -55.45 33.69 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.764 0.316 . . . . 1.0700000000000001 111.593 -179.42 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 3.3 p90 -84.2 -33.34 24.17 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.453 -0.34 . . . . 2.1299999999999999 111.091 -179.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -57.54 -52.13 66.66 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.891 0.377 . . . . 1.95 110.701 179.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -71.93 -42.01 67.15 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.098 -0.501 . . . . 1.0 110.688 179.643 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 3.6 mt -50.21 -48.1 24.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.938 -0.574 . . . . 1.0700000000000001 111.139 179.682 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 101.43 144.01 14.56 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.802 -0.713 . . . . 0.23000000000000001 112.263 -179.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_exo -56.82 -51.96 7.86 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.445 2.097 . . . . 1.1899999999999999 112.575 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.0 -52.07 61.29 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.213 -0.449 . . . . 3.0099999999999998 111.586 -179.447 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' TRP . . . . . 0.404 ' CZ2' ' HA ' ' A' ' 82' ' ' MET . 1.1 t90 -52.07 -40.09 60.65 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.489 -0.323 . . . . 0.54000000000000004 111.135 -179.547 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.411 ' CZ ' ' HB3' ' A' ' 9' ' ' GLU . 5.2 t80 -77.37 -47.54 19.61 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.885 0.374 . . . . 2.52 110.923 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 7.7 mmt180 -56.26 -34.58 66.53 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.133 -0.485 . . . . 3.4100000000000001 111.083 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -92.07 -62.03 1.5 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.14 -0.482 . . . . 1.0900000000000001 111.647 -179.513 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.89 -44.89 14.87 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.357 -0.383 . . . . 2.96 111.387 -179.48 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -65.34 78.59 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.664 -0.779 . . . . 1.26 112.681 -179.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -137.2 11.75 3.84 Favored Glycine 0 CA--C 1.521 0.442 0 C-N-CA 120.693 -0.765 . . . . 1.5900000000000001 113.161 179.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' TRP . . . . . . . . . . . . . 16.6 m95 69.27 -67.89 0.21 Allowed 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 117.042 0.421 . . . . 0.97999999999999998 111.133 179.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 10.1 ttm-85 -53.91 -30.73 47.43 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.387 -0.37 . . . . 3.7200000000000002 110.982 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -73.24 -58.07 4.85 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.792 -0.718 . . . . 0.46000000000000002 112.49 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . 0.438 ' CD2' ' CE2' ' A' ' 39' ' ' TYR . 1.3 mp -60.11 -37.21 79.33 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.857 0.36 . . . . 1.1399999999999999 110.792 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 8.2 tmtt? -63.92 -42.29 97.42 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.125 -0.488 . . . . 2.21 110.691 179.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -80.04 -32.77 39.47 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.159 -0.473 . . . . 1.1299999999999999 111.001 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . 0.413 ' CE1' HG12 ' A' ' 144' ' ' VAL . 4.1 t80 -68.89 -32.69 72.52 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.121 -0.491 . . . . 2.0099999999999998 110.927 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 2.7 t -52.32 -30.27 27.54 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.189 -0.46 . . . . 1.5 111.035 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -94.0 -33.6 13.36 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.269 -0.423 . . . . 1.6100000000000001 111.17 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -62.49 -31.24 71.95 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.186 -0.461 . . . . 3.2400000000000002 110.933 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . 0.413 HG12 ' CE1' ' A' ' 140' ' ' TYR . 16.4 m -49.42 -44.52 18.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.265 -0.425 . . . . 2.46 111.126 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -151.18 115.71 5.13 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.143 -0.481 . . . . 4.3399999999999999 110.964 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 22.7 p . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.15 -0.477 . . . . 3.3100000000000001 111.094 179.901 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.486 1.352 0 CA-C-O 120.794 0.331 . . . . 5.75 111.214 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -163.87 32.73 0.08 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.191 -0.459 . . . . 2.6299999999999999 110.868 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -56.18 90.91 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.188 -0.46 . . . . 2.8399999999999999 110.952 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -105.75 36.89 2.39 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.18 -0.464 . . . . 3.6099999999999999 110.742 179.854 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.586 ' O ' HG12 ' A' ' 5' ' ' VAL . 12.7 t 52.35 25.91 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.056 -0.52 . . . . 2.6899999999999999 111.44 -179.907 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.485 HD11 ' HE1' ' A' ' 134' ' ' TRP . 10.1 tp -178.75 56.67 0.09 OUTLIER Pre-proline 0 C--N 1.331 -0.213 0 CA-C-O 120.96 0.41 . . . . 2.25 110.779 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.434 ' HG2' HD22 ' A' ' 11' ' ' LEU . 36.6 Cg_endo -65.65 -29.42 51.79 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.718 2.278 . . . . 1.3300000000000001 112.298 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -159.23 163.73 33.52 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.812 -0.708 . . . . 0.42999999999999999 112.351 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.425 ' HB3' ' CZ ' ' A' ' 128' ' ' PHE . 4.5 mm-40 -79.86 -57.32 3.71 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.871 0.367 . . . . 1.3200000000000001 110.882 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.58 HG11 ' O ' ' A' ' 116' ' ' PRO . 33.3 m -78.5 -34.92 18.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.104 -0.498 . . . . 0.20000000000000001 111.607 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.434 HD22 ' HG2' ' A' ' 7' ' ' PRO . 9.1 tt -51.77 -28.41 15.26 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.272 -0.422 . . . . 1.3999999999999999 111.237 -179.627 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.811 ' O ' HD12 ' A' ' 16' ' ' ILE . . . -67.93 -41.43 82.59 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.362 -0.381 . . . . 0.23999999999999999 111.509 -179.745 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.405 ' O ' ' CD2' ' A' ' 17' ' ' PHE . 21.8 pt -80.05 -37.61 17.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.501 -0.318 . . . . 0.28000000000000003 111.844 -179.445 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -60.49 -37.03 79.76 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.836 0.351 . . . . 1.78 111.052 -179.787 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.682 ' O ' ' HB3' ' A' ' 19' ' ' ALA . . . -81.55 -52.05 4.34 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.683 -0.77 . . . . 0.47999999999999998 112.733 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.811 HD12 ' O ' ' A' ' 12' ' ' ALA . 3.2 mt -59.36 -19.98 17.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 N-CA-C 112.045 0.387 . . . . 0.33000000000000002 112.045 -179.577 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.55 ' HE1' HG21 ' A' ' 40' ' ' ILE . 8.1 m-85 -91.52 -57.41 2.77 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 112.382 0.512 . . . . 1.23 112.382 -179.185 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' MET . . . . . 0.539 ' CE ' ' HB1' ' A' ' 111' ' ' ALA . 16.1 mmt -84.46 -24.59 29.43 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.148 0.425 . . . . 1.1299999999999999 112.148 -178.934 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.682 ' HB3' ' O ' ' A' ' 15' ' ' GLY . . . -97.13 -51.08 4.34 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.077 0.399 . . . . 0.31 112.077 -179.355 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 4.2 t -86.31 -26.01 25.14 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 111.769 0.285 . . . . 1.3799999999999999 111.769 -179.216 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -48.14 -28.9 6.33 Favored Glycine 0 C--N 1.33 0.212 0 C-N-CA 120.585 -0.817 . . . . 0.48999999999999999 112.69 -179.823 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.469 ' N ' HD13 ' A' ' 22' ' ' LEU . 0.3 OUTLIER -73.98 -34.71 64.32 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.845 0.355 . . . . 0.95999999999999996 110.868 179.957 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 2.0 t30 -147.11 105.98 3.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.228 -0.442 . . . . 2.1899999999999999 110.881 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 12.3 mt-10 -96.4 104.38 17.4 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.226 -0.443 . . . . 2.1400000000000001 110.96 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -67.01 129.4 20.6 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.211 1.94 . . . . 2.02 112.283 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 59.3 mt-10 -108.58 34.49 3.63 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.19 -0.459 . . . . 2.9399999999999999 110.98 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.419 ' CD1' ' N ' ' A' ' 28' ' ' LEU . 41.8 p90 -117.31 -42.97 2.86 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.185 -0.461 . . . . 3.6299999999999999 110.873 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.419 ' N ' ' CD1' ' A' ' 27' ' ' TYR . 12.4 tp -144.0 136.76 27.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.147 -0.478 . . . . 2.3599999999999999 110.799 179.827 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -127.59 87.04 2.56 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.21 -0.45 . . . . 1.25 110.423 -179.896 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -67.1 -52.28 31.47 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.308 -0.405 . . . . 1.7 111.612 -179.418 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_exo -59.45 -157.39 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.297 1.998 . . . . 0.76000000000000001 112.027 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.615 HD13 ' HD2' ' A' ' 35' ' ' PRO . 1.7 pp -44.63 138.99 3.09 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 116.289 -0.414 . . . . 0.45000000000000001 111.057 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 3.9 mp -49.33 -91.55 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.299 -0.41 . . . . 0.96999999999999997 110.605 -179.719 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.479 ' N ' ' CD ' ' A' ' 35' ' ' PRO . 36.4 p -151.86 41.72 0.21 Allowed Pre-proline 0 CA--C 1.534 0.352 0 N-CA-C 112.396 0.517 . . . . 0.5 112.396 179.217 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.615 ' HD2' HD13 ' A' ' 32' ' ' LEU . 54.2 Cg_endo -72.56 -51.22 0.2 Allowed 'Trans proline' 0 C--N 1.353 0.786 0 C-N-CA 121.786 1.657 . . . . 0.20999999999999999 111.511 178.898 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.784 ' O ' HG23 ' A' ' 40' ' ' ILE . 7.1 mm -81.11 -29.73 11.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.718 -0.673 . . . . 0.40999999999999998 110.903 179.541 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.91 -49.1 76.62 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.286 -0.415 . . . . 1.8 110.543 179.844 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 81.2 mt -72.41 -44.52 62.35 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.147 -0.478 . . . . 1.01 110.517 179.642 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.834 ' CE2' HD23 ' A' ' 137' ' ' LEU . 2.7 m-85 -54.38 -52.32 62.02 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.121 -0.49 . . . . 1.22 110.782 179.72 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.784 HG23 ' O ' ' A' ' 36' ' ' ILE . 9.1 pt -68.04 -40.98 84.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.983 -0.553 . . . . 0.28000000000000003 111.31 -179.658 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.1 m -61.16 -38.69 87.34 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.247 -0.433 . . . . 0.27000000000000002 111.35 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -66.68 -53.04 30.03 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.722 -0.751 . . . . 0.23000000000000001 112.777 -179.745 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.899 ' HB3' HG21 ' A' ' 92' ' ' THR . 0.9 OUTLIER -62.59 -52.36 63.7 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.795 0.331 . . . . 0.41999999999999998 111.003 -179.9 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -48.97 -28.05 3.59 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.205 -0.452 . . . . 0.59999999999999998 111.284 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 7.3 ttt180 -67.32 -55.01 15.6 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.735 0.302 . . . . 3.3599999999999999 111.326 -179.701 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -82.03 -52.33 7.14 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.363 -0.381 . . . . 1.3500000000000001 111.44 -179.488 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.435 ' HB3' ' CE2' ' A' ' 51' ' ' PHE . 7.5 mmtt -55.52 -21.97 19.15 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.283 -0.417 . . . . 0.70999999999999996 111.878 -179.578 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 -45.57 -45.88 13.85 Favored 'General case' 0 N--CA 1.462 0.127 0 CA-C-O 120.778 0.323 . . . . 1.74 111.232 -179.773 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 87.5 p -54.78 -30.58 57.18 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.292 -0.413 . . . . 0.56000000000000005 110.884 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.422 HD23 ' N ' ' A' ' 51' ' ' PHE . 6.2 tt -81.82 -54.01 5.71 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.264 -0.425 . . . . 0.51000000000000001 111.085 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.435 ' CE2' ' HB3' ' A' ' 47' ' ' LYS . 17.4 m-85 -59.33 -46.77 87.7 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.403 -0.362 . . . . 1.28 111.059 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.709 ' O ' ' HB3' ' A' ' 56' ' ' ALA . 31.8 mt-10 -50.87 -28.02 8.66 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.361 -0.381 . . . . 1.4399999999999999 111.329 -179.675 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.561 ' O ' HG12 ' A' ' 58' ' ' VAL . . . -79.28 -35.78 40.81 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.826 0.346 . . . . 0.47999999999999998 111.358 -179.841 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' MET . . . . . 0.908 ' O ' HG13 ' A' ' 58' ' ' VAL . 58.2 ttp -84.1 -41.71 16.84 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.285 -0.416 . . . . 1.0 111.244 -179.736 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.529 HD21 HG12 ' A' ' 97' ' ' VAL . 6.9 mp -81.05 -59.05 2.8 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 112.384 0.512 . . . . 0.28999999999999998 112.384 -179.196 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.709 ' HB3' ' O ' ' A' ' 52' ' ' GLU . . . -72.07 -44.62 63.0 Favored 'General case' 0 N--CA 1.463 0.22 0 N-CA-C 113.467 0.914 . . . . 0.48999999999999999 113.467 -177.804 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.531 ' C ' HG12 ' A' ' 58' ' ' VAL . 23.9 t30 -92.1 28.91 1.74 Allowed 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.311 0.485 . . . . 1.6899999999999999 112.311 -178.652 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.908 HG13 ' O ' ' A' ' 54' ' ' MET . 0.5 OUTLIER 167.71 150.65 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 120.815 0.341 . . . . 0.56999999999999995 110.983 179.694 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.4 ' N ' ' CG2' ' A' ' 58' ' ' VAL . 2.6 mpt_? -86.73 104.24 15.94 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.296 -0.411 . . . . 2.8999999999999999 110.45 179.787 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.431 ' CG ' ' CD1' ' A' ' 107' ' ' LEU . 2.8 p90 -46.68 121.32 3.45 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.243 -0.435 . . . . 1.0 111.181 -179.471 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.42 ' CD2' ' HA3' ' A' ' 65' ' ' GLY . 0.4 OUTLIER -70.48 65.65 0.3 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.875 -0.602 . . . . 0.83999999999999997 111.637 -179.574 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.574 ' OG ' HG22 ' A' ' 64' ' ' THR . 0.9 OUTLIER 44.52 -166.77 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.008 -0.542 . . . . 1.02 111.655 179.265 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.427 ' HB ' ' CG ' ' A' ' 110' ' ' PHE . 5.8 t -76.24 -23.82 54.55 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.915 -0.584 . . . . 0.17000000000000001 111.974 -179.699 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.574 HG22 ' OG ' ' A' ' 62' ' ' SER . 6.9 t -50.03 -46.76 53.29 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.737 0.303 . . . . 0.35999999999999999 111.313 -179.467 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.475 ' N ' HG23 ' A' ' 64' ' ' THR . . . -82.24 -47.05 6.27 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.634 -0.793 . . . . 0.23999999999999999 113.143 -179.749 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 28.3 mm -62.95 -43.08 98.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 N-CA-C 111.894 0.331 . . . . 0.38 111.894 -179.317 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -46.85 -58.08 4.27 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.87 0.367 . . . . 1.48 111.301 -179.709 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 39.9 tt0 -56.04 -31.3 63.02 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.322 -0.399 . . . . 1.6100000000000001 111.319 -179.799 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 16.9 tp -80.2 -61.04 2.1 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.347 -0.388 . . . . 1.2 111.718 -179.528 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -80.68 -55.15 3.45 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.752 -0.737 . . . . 0.22 113.338 -179.202 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.825 HD21 ' CD2' ' A' ' 118' ' ' TYR . 0.2 OUTLIER -52.68 -25.24 10.36 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.771 0.32 . . . . 0.70999999999999996 111.016 -179.544 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -51.65 -25.54 7.32 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.701 -0.227 . . . . 1.1399999999999999 111.198 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' MET . . . . . 0.461 ' HE3' ' C ' ' A' ' 73' ' ' MET . 0.0 OUTLIER -49.77 -30.73 10.07 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.748 0.309 . . . . 0.26000000000000001 110.96 179.894 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 1.014 HD12 ' HB2' ' A' ' 122' ' ' ALA . 0.4 OUTLIER -69.88 -52.05 28.0 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.271 -0.422 . . . . 1.3799999999999999 110.957 -179.785 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 30.2 tt0 -53.92 -30.43 46.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.258 -0.428 . . . . 1.8899999999999999 110.97 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 6.6 p -94.27 -29.13 4.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.216 -0.447 . . . . 0.42999999999999999 111.318 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 43.3 t -96.2 40.01 1.14 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.36 -0.382 . . . . 0.93999999999999995 111.062 -179.813 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -65.41 -27.9 72.99 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.689 -0.767 . . . . 1.4299999999999999 112.354 179.837 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -176.38 88.21 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.86 0.362 . . . . 3.1000000000000001 110.837 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -122.05 -144.67 6.86 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.75 -0.738 . . . . 1.78 112.576 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 66.1 m-20 -128.29 98.13 4.98 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.819 0.342 . . . . 2.46 110.998 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' MET . . . . . 0.417 ' HA ' ' CZ2' ' A' ' 127' ' ' TRP . 3.8 mtp 49.1 93.75 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.23 -0.441 . . . . 0.85999999999999999 110.97 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 7.6 m120 -123.01 49.62 1.63 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.205 -0.452 . . . . 1.25 110.916 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' TRP . . . . . 0.477 ' CZ2' HD21 ' A' ' 137' ' ' LEU . 8.4 m95 -49.64 -33.41 15.43 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.297 -0.411 . . . . 0.34000000000000002 110.791 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -56.12 -34.68 62.71 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.707 -0.758 . . . . 0.20000000000000001 112.313 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 8.3 mpt_? -64.41 -72.11 0.16 Allowed 'General case' 0 C--O 1.235 0.308 0 CA-C-O 121.011 0.434 . . . . 1.8799999999999999 110.647 179.844 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.511 ' C ' HD12 ' A' ' 91' ' ' LEU . . . -50.68 -33.72 23.8 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.042 -0.527 . . . . 0.16 110.219 179.392 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.631 ' CD2' HD13 ' A' ' 43' ' ' LEU . 17.1 tp -66.79 -32.45 73.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.828 -0.624 . . . . 0.73999999999999999 110.432 179.364 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -57.47 -53.57 56.65 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.975 -0.557 . . . . 0.14999999999999999 111.023 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.585 ' O ' HD11 ' A' ' 115' ' ' LEU . 4.8 tt -78.52 -29.22 14.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 C-N-CA 120.938 -0.305 . . . . 0.5 111.152 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.511 HD12 ' C ' ' A' ' 87' ' ' ALA . 19.3 mt -66.49 -65.16 0.71 Allowed 'General case' 0 C--O 1.233 0.23 0 CA-C-O 121.031 0.443 . . . . 1.24 110.115 179.336 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.899 HG21 ' HB3' ' A' ' 43' ' ' LEU . 48.3 m -54.43 -41.46 69.4 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.033 -0.531 . . . . 0.17000000000000001 109.963 179.136 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.915 ' CZ ' HG11 ' A' ' 97' ' ' VAL . 8.7 t80 -51.02 -41.43 59.79 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 115.721 -0.672 . . . . 0.19 109.946 179.207 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.585 ' O ' ' HB2' ' A' ' 98' ' ' ALA . . . -59.79 -40.88 97.26 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.816 -0.707 . . . . 0.14000000000000001 112.146 179.516 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 1.3 t -66.27 -54.08 29.16 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.096 0.474 . . . . 0.32000000000000001 110.713 179.749 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 23.6 t80 -57.92 -57.04 14.56 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.963 -0.562 . . . . 1.1299999999999999 110.539 179.787 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.915 HG11 ' CZ ' ' A' ' 93' ' ' PHE . 10.4 m -59.52 -35.18 57.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.891 -0.595 . . . . 0.13 110.899 179.84 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.585 ' HB2' ' O ' ' A' ' 94' ' ' GLY . . . -50.07 -38.73 39.57 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.024 0.44 . . . . 0.17000000000000001 110.144 179.3 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -69.37 -39.46 78.05 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.813 -0.63 . . . . 1.53 110.301 179.125 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -83.01 -2.0 54.12 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 116.006 -0.543 . . . . 0.93999999999999995 112.039 179.859 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.758 HD11 ' HB2' ' A' ' 107' ' ' LEU . 0.0 OUTLIER -88.23 -15.76 35.05 Favored 'General case' 0 N--CA 1.462 0.144 0 N-CA-C 112.013 0.375 . . . . 0.80000000000000004 112.013 -179.544 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 4.0 t -51.45 -26.93 8.97 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.652 0.263 . . . . 0.81000000000000005 110.766 -179.818 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -101.29 -29.64 11.95 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.483 -0.326 . . . . 1.3300000000000001 110.892 179.576 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.409 ' HB2' ' CE1' ' A' ' 60' ' ' PHE . 2.4 mm-40 -130.23 95.45 27.66 Favored Pre-proline 0 C--N 1.331 -0.21 0 CA-C-N 116.31 -0.405 . . . . 1.5600000000000001 110.855 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -71.49 -4.76 15.64 Favored 'Trans proline' 0 CA--C 1.532 0.381 0 C-N-CA 122.739 2.293 . . . . 0.62 113.559 -179.802 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 62.0 m170 -49.65 -52.12 33.06 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.707 0.289 . . . . 1.3400000000000001 111.206 -179.501 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.758 ' HB2' HD11 ' A' ' 101' ' ' LEU . 21.4 mt -73.04 -22.27 60.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.89 0.376 . . . . 0.31 111.151 179.752 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 1.7 ttp180 -75.49 -20.84 58.51 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.679 0.276 . . . . 1.5800000000000001 111.096 179.594 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -73.48 -51.31 17.58 Favored 'General case' 0 C--O 1.234 0.248 0 N-CA-C 111.815 0.302 . . . . 1.0900000000000001 111.815 -179.548 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.446 ' CD1' ' O ' ' A' ' 107' ' ' LEU . 2.5 p90 -65.81 -41.9 91.31 Favored 'General case' 0 C--O 1.224 -0.286 0 C-N-CA 120.782 -0.367 . . . . 0.73999999999999999 110.472 -179.313 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.539 ' HB1' ' CE ' ' A' ' 18' ' ' MET . . . -45.73 -30.81 1.73 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.876 0.369 . . . . 0.13 111.419 -179.871 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 36.1 mt -81.06 -44.54 17.88 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.373 -0.376 . . . . 0.40000000000000002 111.262 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -89.43 2.54 54.34 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 113.207 0.818 . . . . 0.20000000000000001 113.207 -179.093 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.509 HG12 ' N ' ' A' ' 115' ' ' LEU . 1.2 t -132.16 -51.14 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.138 0 N-CA-C 112.797 0.666 . . . . 0.16 112.797 -178.396 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.597 ' O ' ' HB2' ' A' ' 119' ' ' ALA . 0.3 OUTLIER -49.65 -56.56 16.1 Favored Pre-proline 0 C--N 1.328 -0.362 0 N-CA-C 111.969 0.359 . . . . 0.26000000000000001 111.969 -178.701 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.58 ' O ' HG11 ' A' ' 10' ' ' VAL . 30.3 Cg_endo -63.12 -51.18 2.96 Favored 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 122.019 1.813 . . . . 0.34000000000000002 112.839 -179.584 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -57.02 -54.0 51.65 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.301 -0.409 . . . . 0.29999999999999999 111.954 -179.366 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' TYR . . . . . 0.825 ' CD2' HD21 ' A' ' 71' ' ' LEU . 9.0 m-85 -71.83 -26.03 62.21 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.409 -0.359 . . . . 1.21 111.88 -179.21 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.597 ' HB2' ' O ' ' A' ' 115' ' ' LEU . . . -56.53 -55.45 33.69 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.764 0.316 . . . . 0.26000000000000001 111.593 -179.42 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 3.3 p90 -84.2 -33.34 24.17 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.453 -0.34 . . . . 1.22 111.091 -179.802 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -57.54 -52.13 66.66 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.891 0.377 . . . . 1.95 110.701 179.819 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 1.014 ' HB2' HD12 ' A' ' 74' ' ' LEU . . . -71.93 -42.01 67.15 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.098 -0.501 . . . . 0.22 110.688 179.643 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.589 HD12 ' O ' ' A' ' 119' ' ' ALA . 3.6 mt -50.21 -48.1 24.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.938 -0.574 . . . . 0.22 111.139 179.682 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 101.43 144.01 14.56 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.802 -0.713 . . . . 0.23000000000000001 112.263 -179.863 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_exo -56.82 -51.96 7.86 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.445 2.097 . . . . 0.76000000000000001 112.575 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.0 -52.07 61.29 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.213 -0.449 . . . . 2.3799999999999999 111.586 -179.447 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 127' ' ' TRP . . . . . 0.417 ' CZ2' ' HA ' ' A' ' 82' ' ' MET . 1.1 t90 -52.07 -40.09 60.65 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.489 -0.323 . . . . 0.41999999999999998 111.135 -179.547 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.425 ' CZ ' ' HB3' ' A' ' 9' ' ' GLU . 5.2 t80 -77.37 -47.54 19.61 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.885 0.374 . . . . 1.6000000000000001 110.923 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 7.7 mmt180 -56.26 -34.58 66.53 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.133 -0.485 . . . . 2.9500000000000002 111.083 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -92.07 -62.03 1.5 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.14 -0.482 . . . . 0.56000000000000005 111.647 -179.513 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.89 -44.89 14.87 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.357 -0.383 . . . . 2.2599999999999998 111.387 -179.48 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -65.34 78.59 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.664 -0.779 . . . . 1.26 112.681 -179.785 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -137.2 11.75 3.84 Favored Glycine 0 CA--C 1.521 0.442 0 C-N-CA 120.693 -0.765 . . . . 1.5900000000000001 113.161 179.786 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' TRP . . . . . 0.485 ' HE1' HD11 ' A' ' 6' ' ' LEU . 16.6 m95 69.27 -67.89 0.21 Allowed 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 117.042 0.421 . . . . 0.56000000000000005 111.133 179.859 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 10.1 ttm-85 -53.91 -30.73 47.43 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.387 -0.37 . . . . 3.1899999999999999 110.982 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -73.24 -58.07 4.85 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.792 -0.718 . . . . 0.40999999999999998 112.49 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.834 HD23 ' CE2' ' A' ' 39' ' ' TYR . 1.3 mp -60.11 -37.21 79.33 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.857 0.36 . . . . 0.33000000000000002 110.792 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 8.2 tmtt? -63.92 -42.29 97.42 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.125 -0.488 . . . . 1.55 110.691 179.833 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -80.04 -32.77 39.47 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.159 -0.473 . . . . 0.42999999999999999 111.001 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' TYR . . . . . 0.431 ' O ' HG13 ' A' ' 144' ' ' VAL . 4.1 t80 -68.89 -32.69 72.52 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.121 -0.491 . . . . 1.1699999999999999 110.927 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 141' ' ' CYS . . . . . 0.574 ' O ' HG22 ' A' ' 144' ' ' VAL . 2.7 t -52.32 -30.27 27.54 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.189 -0.46 . . . . 0.84999999999999998 111.035 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 142' ' ' THR . . . . . 0.62 ' O ' HG23 ' A' ' 146' ' ' THR . 0.3 OUTLIER -94.0 -33.6 13.36 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.269 -0.423 . . . . 1.3 111.17 -179.926 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -62.49 -31.24 71.95 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.186 -0.461 . . . . 2.5800000000000001 110.933 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.574 HG22 ' O ' ' A' ' 141' ' ' CYS . 16.4 m -49.42 -44.52 18.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.265 -0.425 . . . . 1.8200000000000001 111.126 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.431 ' N ' HG23 ' A' ' 144' ' ' VAL . 1.0 OUTLIER -151.18 115.71 5.13 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.143 -0.481 . . . . 3.9100000000000001 110.964 179.978 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.62 HG23 ' O ' ' A' ' 142' ' ' THR . 22.7 p . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.15 -0.477 . . . . 3.1299999999999999 111.094 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.486 1.352 0 CA-C-O 120.794 0.331 . . . . 5.75 111.214 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -163.87 32.73 0.08 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.191 -0.459 . . . . 2.63 110.868 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -56.18 90.91 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.188 -0.46 . . . . 2.84 110.952 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -105.75 36.89 2.39 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.18 -0.464 . . . . 3.61 110.742 179.854 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.586 HG12 ' O ' ' A' ' 5' ' ' VAL . 12.7 t 52.35 25.91 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.056 -0.52 . . . . 2.69 111.44 -179.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.485 HD11 ' HE1' ' A' ' 134' ' ' TRP . 10.1 tp -178.75 56.67 0.09 OUTLIER Pre-proline 0 C--N 1.331 -0.213 0 CA-C-O 120.96 0.41 . . . . 2.25 110.779 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.434 ' HG2' HD22 ' A' ' 11' ' ' LEU . 36.6 Cg_endo -65.65 -29.42 51.79 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.718 2.278 . . . . 1.33 112.298 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -159.23 163.73 33.52 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.812 -0.708 . . . . 0.43 112.351 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.425 ' HB3' ' CZ ' ' A' ' 128' ' ' PHE . 4.5 mm-40 -79.86 -57.32 3.71 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.871 0.367 . . . . 1.32 110.882 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.58 HG11 ' O ' ' A' ' 116' ' ' PRO . 33.3 m -78.5 -34.92 18.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.104 -0.498 . . . . 0.2 111.607 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.434 HD22 ' HG2' ' A' ' 7' ' ' PRO . 9.1 tt -51.77 -28.41 15.26 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.272 -0.422 . . . . 1.4 111.237 -179.627 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.811 ' O ' HD12 ' A' ' 16' ' ' ILE . . . -67.93 -41.43 82.59 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.362 -0.381 . . . . 0.24 111.509 -179.745 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.405 ' O ' ' CD2' ' A' ' 17' ' ' PHE . 21.8 pt -80.05 -37.61 17.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.501 -0.318 . . . . 0.28 111.844 -179.445 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -60.49 -37.03 79.76 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.836 0.351 . . . . 1.78 111.052 -179.787 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.682 ' O ' ' HB3' ' A' ' 19' ' ' ALA . . . -81.55 -52.05 4.34 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.683 -0.77 . . . . 0.48 112.733 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.811 HD12 ' O ' ' A' ' 12' ' ' ALA . 3.2 mt -59.36 -19.98 17.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 N-CA-C 112.045 0.387 . . . . 0.33 112.045 -179.577 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.55 ' HE1' HG21 ' A' ' 40' ' ' ILE . 8.1 m-85 -91.52 -57.41 2.77 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 112.382 0.512 . . . . 1.23 112.382 -179.185 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . 0.539 ' CE ' ' HB1' ' A' ' 111' ' ' ALA . 16.1 mmt -84.46 -24.59 29.43 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.148 0.425 . . . . 1.13 112.148 -178.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.682 ' HB3' ' O ' ' A' ' 15' ' ' GLY . . . -97.13 -51.08 4.34 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.077 0.399 . . . . 0.31 112.077 -179.355 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 4.2 t -86.31 -26.01 25.14 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 111.769 0.285 . . . . 1.38 111.769 -179.216 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -48.14 -28.9 6.33 Favored Glycine 0 C--N 1.33 0.212 0 C-N-CA 120.585 -0.817 . . . . 0.49 112.69 -179.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.469 ' N ' HD13 ' A' ' 22' ' ' LEU . 0.3 OUTLIER -73.98 -34.71 64.32 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.845 0.355 . . . . 0.96 110.868 179.957 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 2.0 t30 -147.11 105.98 3.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.228 -0.442 . . . . 2.19 110.881 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 12.3 mt-10 -96.4 104.38 17.4 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.226 -0.443 . . . . 2.14 110.96 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -67.01 129.4 20.6 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.211 1.94 . . . . 2.02 112.283 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 59.3 mt-10 -108.58 34.49 3.63 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.19 -0.459 . . . . 2.94 110.98 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.419 ' CD1' ' N ' ' A' ' 28' ' ' LEU . 41.8 p90 -117.31 -42.97 2.86 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.185 -0.461 . . . . 3.63 110.873 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.419 ' N ' ' CD1' ' A' ' 27' ' ' TYR . 12.4 tp -144.0 136.76 27.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.147 -0.478 . . . . 2.36 110.799 179.827 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -127.59 87.04 2.56 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.21 -0.45 . . . . 1.25 110.423 -179.896 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -67.1 -52.28 31.47 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.308 -0.405 . . . . 1.7 111.612 -179.418 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_exo -59.45 -157.39 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.297 1.998 . . . . 0.76 112.027 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.615 HD13 ' HD2' ' A' ' 35' ' ' PRO . 1.7 pp -44.63 138.99 3.09 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 116.289 -0.414 . . . . 0.45 111.057 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 3.9 mp -49.33 -91.55 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.299 -0.41 . . . . 0.97 110.605 -179.719 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.479 ' N ' ' CD ' ' A' ' 35' ' ' PRO . 36.4 p -151.86 41.72 0.21 Allowed Pre-proline 0 CA--C 1.534 0.352 0 N-CA-C 112.396 0.517 . . . . 0.5 112.396 179.217 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.615 ' HD2' HD13 ' A' ' 32' ' ' LEU . 54.2 Cg_endo -72.56 -51.22 0.2 Allowed 'Trans proline' 0 C--N 1.353 0.786 0 C-N-CA 121.786 1.657 . . . . 0.21 111.511 178.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.784 ' O ' HG23 ' A' ' 40' ' ' ILE . 7.1 mm -81.11 -29.73 11.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.718 -0.673 . . . . 0.41 110.903 179.541 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.91 -49.1 76.62 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.286 -0.415 . . . . 1.8 110.543 179.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 81.2 mt -72.41 -44.52 62.35 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.147 -0.478 . . . . 1.01 110.517 179.642 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.834 ' CE2' HD23 ' A' ' 137' ' ' LEU . 2.7 m-85 -54.38 -52.32 62.02 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.121 -0.49 . . . . 1.22 110.782 179.72 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.784 HG23 ' O ' ' A' ' 36' ' ' ILE . 9.1 pt -68.04 -40.98 84.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.983 -0.553 . . . . 0.28 111.31 -179.658 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.1 m -61.16 -38.69 87.34 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.247 -0.433 . . . . 0.27 111.35 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -66.68 -53.04 30.03 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.722 -0.751 . . . . 0.23 112.777 -179.745 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.899 ' HB3' HG21 ' A' ' 92' ' ' THR . 0.9 OUTLIER -62.59 -52.36 63.7 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.795 0.331 . . . . 0.42 111.003 -179.9 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -48.97 -28.05 3.59 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.205 -0.452 . . . . 0.6 111.284 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 7.3 ttt180 -67.32 -55.01 15.6 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.735 0.302 . . . . 3.36 111.326 -179.701 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -82.03 -52.33 7.14 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.363 -0.381 . . . . 1.35 111.44 -179.488 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.435 ' HB3' ' CE2' ' A' ' 51' ' ' PHE . 7.5 mmtt -55.52 -21.97 19.15 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.283 -0.417 . . . . 0.71 111.878 -179.578 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 -45.57 -45.88 13.85 Favored 'General case' 0 N--CA 1.462 0.127 0 CA-C-O 120.778 0.323 . . . . 1.74 111.232 -179.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 87.5 p -54.78 -30.58 57.18 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.292 -0.413 . . . . 0.56 110.884 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.422 HD23 ' N ' ' A' ' 51' ' ' PHE . 6.2 tt -81.82 -54.01 5.71 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.264 -0.425 . . . . 0.51 111.085 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.435 ' CE2' ' HB3' ' A' ' 47' ' ' LYS . 17.4 m-85 -59.33 -46.77 87.7 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.403 -0.362 . . . . 1.28 111.059 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.709 ' O ' ' HB3' ' A' ' 56' ' ' ALA . 31.8 mt-10 -50.87 -28.02 8.66 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.361 -0.381 . . . . 1.44 111.329 -179.675 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.561 ' O ' HG12 ' A' ' 58' ' ' VAL . . . -79.28 -35.78 40.81 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.826 0.346 . . . . 0.48 111.358 -179.841 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . 0.908 ' O ' HG13 ' A' ' 58' ' ' VAL . 58.2 ttp -84.1 -41.71 16.84 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.285 -0.416 . . . . 1.0 111.244 -179.736 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.529 HD21 HG12 ' A' ' 97' ' ' VAL . 6.9 mp -81.05 -59.05 2.8 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 112.384 0.512 . . . . 0.29 112.384 -179.196 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.709 ' HB3' ' O ' ' A' ' 52' ' ' GLU . . . -72.07 -44.62 63.0 Favored 'General case' 0 N--CA 1.463 0.22 0 N-CA-C 113.467 0.914 . . . . 0.49 113.467 -177.804 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.531 ' C ' HG12 ' A' ' 58' ' ' VAL . 23.9 t30 -92.1 28.91 1.74 Allowed 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.311 0.485 . . . . 1.69 112.311 -178.652 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.908 HG13 ' O ' ' A' ' 54' ' ' MET . 0.5 OUTLIER 167.71 150.65 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 120.815 0.341 . . . . 0.57 110.983 179.694 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.4 ' N ' ' CG2' ' A' ' 58' ' ' VAL . 2.6 mpt_? -86.73 104.24 15.94 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.296 -0.411 . . . . 2.9 110.45 179.787 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.431 ' CG ' ' CD1' ' A' ' 107' ' ' LEU . 2.8 p90 -46.68 121.32 3.45 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.243 -0.435 . . . . 1.0 111.181 -179.471 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.42 ' CD2' ' HA3' ' A' ' 65' ' ' GLY . 0.4 OUTLIER -70.48 65.65 0.3 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.875 -0.602 . . . . 0.84 111.637 -179.574 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.574 ' OG ' HG22 ' A' ' 64' ' ' THR . 0.9 OUTLIER 44.52 -166.77 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.008 -0.542 . . . . 1.02 111.655 179.265 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.427 ' HB ' ' CG ' ' A' ' 110' ' ' PHE . 5.8 t -76.24 -23.82 54.55 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.915 -0.584 . . . . 0.17 111.974 -179.699 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.574 HG22 ' OG ' ' A' ' 62' ' ' SER . 6.9 t -50.03 -46.76 53.29 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.737 0.303 . . . . 0.36 111.313 -179.467 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.475 ' N ' HG23 ' A' ' 64' ' ' THR . . . -82.24 -47.05 6.27 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.634 -0.793 . . . . 0.24 113.143 -179.749 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 28.3 mm -62.95 -43.08 98.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 N-CA-C 111.894 0.331 . . . . 0.38 111.894 -179.317 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -46.85 -58.08 4.27 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.87 0.367 . . . . 1.48 111.301 -179.709 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 39.9 tt0 -56.04 -31.3 63.02 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.322 -0.399 . . . . 1.61 111.319 -179.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 16.9 tp -80.2 -61.04 2.1 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.347 -0.388 . . . . 1.2 111.718 -179.528 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -80.68 -55.15 3.45 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.752 -0.737 . . . . 0.22 113.338 -179.202 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.825 HD21 ' CD2' ' A' ' 118' ' ' TYR . 0.2 OUTLIER -52.68 -25.24 10.36 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.771 0.32 . . . . 0.71 111.016 -179.544 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -51.65 -25.54 7.32 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.701 -0.227 . . . . 1.14 111.198 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . 0.461 ' HE3' ' C ' ' A' ' 73' ' ' MET . 0.0 OUTLIER -49.77 -30.73 10.07 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.748 0.309 . . . . 0.26 110.96 179.894 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 1.014 HD12 ' HB2' ' A' ' 122' ' ' ALA . 0.4 OUTLIER -69.88 -52.05 28.0 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.271 -0.422 . . . . 1.38 110.957 -179.785 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 30.2 tt0 -53.92 -30.43 46.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.258 -0.428 . . . . 1.89 110.97 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 6.6 p -94.27 -29.13 4.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.216 -0.447 . . . . 0.43 111.318 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 43.3 t -96.2 40.01 1.14 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.36 -0.382 . . . . 0.94 111.062 -179.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -65.41 -27.9 72.99 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.689 -0.767 . . . . 1.43 112.354 179.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -176.38 88.21 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.86 0.362 . . . . 3.1 110.837 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -122.05 -144.67 6.86 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.75 -0.738 . . . . 1.78 112.576 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 66.1 m-20 -128.29 98.13 4.98 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.819 0.342 . . . . 2.46 110.998 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . 0.417 ' HA ' ' CZ2' ' A' ' 127' ' ' TRP . 3.8 mtp 49.1 93.75 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.23 -0.441 . . . . 0.86 110.97 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 7.6 m120 -123.01 49.62 1.63 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.205 -0.452 . . . . 1.25 110.916 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' TRP . . . . . 0.477 ' CZ2' HD21 ' A' ' 137' ' ' LEU . 8.4 m95 -49.64 -33.41 15.43 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.297 -0.411 . . . . 0.34 110.791 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -56.12 -34.68 62.71 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.707 -0.758 . . . . 0.2 112.313 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 8.3 mpt_? -64.41 -72.11 0.16 Allowed 'General case' 0 C--O 1.235 0.308 0 CA-C-O 121.011 0.434 . . . . 1.88 110.647 179.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.511 ' C ' HD12 ' A' ' 91' ' ' LEU . . . -50.68 -33.72 23.8 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.042 -0.527 . . . . 0.16 110.219 179.392 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.631 ' CD2' HD13 ' A' ' 43' ' ' LEU . 17.1 tp -66.79 -32.45 73.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.828 -0.624 . . . . 0.74 110.432 179.364 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -57.47 -53.57 56.65 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.975 -0.557 . . . . 0.15 111.023 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.585 ' O ' HD11 ' A' ' 115' ' ' LEU . 4.8 tt -78.52 -29.22 14.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 C-N-CA 120.938 -0.305 . . . . 0.5 111.152 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.511 HD12 ' C ' ' A' ' 87' ' ' ALA . 19.3 mt -66.49 -65.16 0.71 Allowed 'General case' 0 C--O 1.233 0.23 0 CA-C-O 121.031 0.443 . . . . 1.24 110.115 179.336 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.899 HG21 ' HB3' ' A' ' 43' ' ' LEU . 48.3 m -54.43 -41.46 69.4 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.033 -0.531 . . . . 0.17 109.963 179.136 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.915 ' CZ ' HG11 ' A' ' 97' ' ' VAL . 8.7 t80 -51.02 -41.43 59.79 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 115.721 -0.672 . . . . 0.19 109.946 179.207 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.585 ' O ' ' HB2' ' A' ' 98' ' ' ALA . . . -59.79 -40.88 97.26 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.816 -0.707 . . . . 0.14 112.146 179.516 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 1.3 t -66.27 -54.08 29.16 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.096 0.474 . . . . 0.32 110.713 179.749 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 23.6 t80 -57.92 -57.04 14.56 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.963 -0.562 . . . . 1.13 110.539 179.787 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.915 HG11 ' CZ ' ' A' ' 93' ' ' PHE . 10.4 m -59.52 -35.18 57.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.891 -0.595 . . . . 0.13 110.899 179.84 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.585 ' HB2' ' O ' ' A' ' 94' ' ' GLY . . . -50.07 -38.73 39.57 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.024 0.44 . . . . 0.17 110.144 179.3 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -69.37 -39.46 78.05 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.813 -0.63 . . . . 1.53 110.301 179.125 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -83.01 -2.0 54.12 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 116.006 -0.543 . . . . 0.94 112.039 179.859 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.758 HD11 ' HB2' ' A' ' 107' ' ' LEU . 0.0 OUTLIER -88.23 -15.76 35.05 Favored 'General case' 0 N--CA 1.462 0.144 0 N-CA-C 112.013 0.375 . . . . 0.8 112.013 -179.544 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 4.0 t -51.45 -26.93 8.97 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.652 0.263 . . . . 0.81 110.766 -179.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -101.29 -29.64 11.95 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.483 -0.326 . . . . 1.33 110.892 179.576 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.409 ' HB2' ' CE1' ' A' ' 60' ' ' PHE . 2.4 mm-40 -130.23 95.45 27.66 Favored Pre-proline 0 C--N 1.331 -0.21 0 CA-C-N 116.31 -0.405 . . . . 1.56 110.855 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -71.49 -4.76 15.64 Favored 'Trans proline' 0 CA--C 1.532 0.381 0 C-N-CA 122.739 2.293 . . . . 0.62 113.559 -179.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 62.0 m170 -49.65 -52.12 33.06 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.707 0.289 . . . . 1.34 111.206 -179.501 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.758 ' HB2' HD11 ' A' ' 101' ' ' LEU . 21.4 mt -73.04 -22.27 60.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.89 0.376 . . . . 0.31 111.151 179.752 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 1.7 ttp180 -75.49 -20.84 58.51 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.679 0.276 . . . . 1.58 111.096 179.594 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -73.48 -51.31 17.58 Favored 'General case' 0 C--O 1.234 0.248 0 N-CA-C 111.815 0.302 . . . . 1.09 111.815 -179.548 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.446 ' CD1' ' O ' ' A' ' 107' ' ' LEU . 2.5 p90 -65.81 -41.9 91.31 Favored 'General case' 0 C--O 1.224 -0.286 0 C-N-CA 120.782 -0.367 . . . . 0.74 110.472 -179.313 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.539 ' HB1' ' CE ' ' A' ' 18' ' ' MET . . . -45.73 -30.81 1.73 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.876 0.369 . . . . 0.13 111.419 -179.871 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 36.1 mt -81.06 -44.54 17.88 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.373 -0.376 . . . . 0.4 111.262 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -89.43 2.54 54.34 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 113.207 0.818 . . . . 0.2 113.207 -179.093 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.509 HG12 ' N ' ' A' ' 115' ' ' LEU . 1.2 t -132.16 -51.14 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.138 0 N-CA-C 112.797 0.666 . . . . 0.16 112.797 -178.396 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.597 ' O ' ' HB2' ' A' ' 119' ' ' ALA . 0.3 OUTLIER -49.65 -56.56 16.1 Favored Pre-proline 0 C--N 1.328 -0.362 0 N-CA-C 111.969 0.359 . . . . 0.26 111.969 -178.701 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.58 ' O ' HG11 ' A' ' 10' ' ' VAL . 30.3 Cg_endo -63.12 -51.18 2.96 Favored 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 122.019 1.813 . . . . 0.34 112.839 -179.584 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -57.02 -54.0 51.65 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.301 -0.409 . . . . 0.3 111.954 -179.366 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . 0.825 ' CD2' HD21 ' A' ' 71' ' ' LEU . 9.0 m-85 -71.83 -26.03 62.21 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.409 -0.359 . . . . 1.21 111.88 -179.21 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.597 ' HB2' ' O ' ' A' ' 115' ' ' LEU . . . -56.53 -55.45 33.69 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.764 0.316 . . . . 0.26 111.593 -179.42 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 3.3 p90 -84.2 -33.34 24.17 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.453 -0.34 . . . . 1.22 111.091 -179.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -57.54 -52.13 66.66 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.891 0.377 . . . . 1.95 110.701 179.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 1.014 ' HB2' HD12 ' A' ' 74' ' ' LEU . . . -71.93 -42.01 67.15 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.098 -0.501 . . . . 0.22 110.688 179.643 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.589 HD12 ' O ' ' A' ' 119' ' ' ALA . 3.6 mt -50.21 -48.1 24.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.938 -0.574 . . . . 0.22 111.139 179.682 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 101.43 144.01 14.56 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.802 -0.713 . . . . 0.23 112.263 -179.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_exo -56.82 -51.96 7.86 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.445 2.097 . . . . 0.76 112.575 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.0 -52.07 61.29 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.213 -0.449 . . . . 2.38 111.586 -179.447 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' TRP . . . . . 0.417 ' CZ2' ' HA ' ' A' ' 82' ' ' MET . 1.1 t90 -52.07 -40.09 60.65 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.489 -0.323 . . . . 0.42 111.135 -179.547 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.425 ' CZ ' ' HB3' ' A' ' 9' ' ' GLU . 5.2 t80 -77.37 -47.54 19.61 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.885 0.374 . . . . 1.6 110.923 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 7.7 mmt180 -56.26 -34.58 66.53 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.133 -0.485 . . . . 2.95 111.083 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -92.07 -62.03 1.5 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.14 -0.482 . . . . 0.56 111.647 -179.513 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.89 -44.89 14.87 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.357 -0.383 . . . . 2.26 111.387 -179.48 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -65.34 78.59 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.664 -0.779 . . . . 1.26 112.681 -179.785 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -137.2 11.75 3.84 Favored Glycine 0 CA--C 1.521 0.442 0 C-N-CA 120.693 -0.765 . . . . 1.59 113.161 179.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' TRP . . . . . 0.485 ' HE1' HD11 ' A' ' 6' ' ' LEU . 16.6 m95 69.27 -67.89 0.21 Allowed 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 117.042 0.421 . . . . 0.56 111.133 179.859 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 10.1 ttm-85 -53.91 -30.73 47.43 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.387 -0.37 . . . . 3.19 110.982 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -73.24 -58.07 4.85 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.792 -0.718 . . . . 0.41 112.49 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.834 HD23 ' CE2' ' A' ' 39' ' ' TYR . 1.3 mp -60.11 -37.21 79.33 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.857 0.36 . . . . 0.33 110.792 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 8.2 tmtt? -63.92 -42.29 97.42 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.125 -0.488 . . . . 1.55 110.691 179.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -80.04 -32.77 39.47 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.159 -0.473 . . . . 0.43 111.001 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . 0.431 ' O ' HG13 ' A' ' 144' ' ' VAL . 4.1 t80 -68.89 -32.69 72.52 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.121 -0.491 . . . . 1.17 110.927 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' CYS . . . . . 0.574 ' O ' HG22 ' A' ' 144' ' ' VAL . 2.7 t -52.32 -30.27 27.54 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.189 -0.46 . . . . 0.85 111.035 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . 0.62 ' O ' HG23 ' A' ' 146' ' ' THR . 0.3 OUTLIER -94.0 -33.6 13.36 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.269 -0.423 . . . . 1.3 111.17 -179.926 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -62.49 -31.24 71.95 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.186 -0.461 . . . . 2.58 110.933 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.574 HG22 ' O ' ' A' ' 141' ' ' CYS . 16.4 m -49.42 -44.52 18.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.265 -0.425 . . . . 1.82 111.126 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.431 ' N ' HG23 ' A' ' 144' ' ' VAL . 1.0 OUTLIER -151.18 115.71 5.13 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.143 -0.481 . . . . 3.91 110.964 179.978 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.62 HG23 ' O ' ' A' ' 142' ' ' THR . 22.7 p . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.15 -0.477 . . . . 3.13 111.094 179.901 . . . . . . . . 1 1 . 1 stop_ save_